Coronary artery stents and non-cardiac surgery

被引:80
作者
Howard-Alpe, G. M.
de Bono, J.
Hudsmith, L.
Orr, W. P.
Foex, P.
Sear, J. W.
机构
[1] Univ Oxford, Nuffield Dept Anaesthet, John Radcliffe Hosp, Oxford OX3 9DU, England
[2] Univ Oxford, Dept Cardiovasc Med, John Radcliffe Hosp, Oxford OX3 9DU, England
[3] Royal Berkshire Hosp, Dept Cardiol, Reading RG1 5AN, Berks, England
关键词
anaesthetic techniques; regional; coronary stenosis; drug therapy; platelet aggregation inhibitors; therapeutic use; stents; surgery; non-cardiac;
D O I
10.1093/bja/aem089
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The utility of interventional cardiology has developed significantly over the last two decades with the introduction of coronary angioplasty and stenting, with the associated antiplatelet medications. Acute coronary stent occlusion carries a high morbidity and mortality, and the adoption of therapeutic strategies for prophylaxis against stent thrombosis has major implications for surgeons and anaesthetists involved in the management of these patients in the perioperative period. Currently, there is limited published information to guide the clinician in the optimal care of patients who have had coronary stents inserted when they present for non-cardiac surgery. This review examines the available literature on the perioperative management of these patients. A number of key issues are identified: the role of surgery vs percutaneous coronary intervention for coronary revascularization in the preoperative period; the different types of coronary stents currently available; the emerging issues related to drug-eluting stents; the pathophysiology of coronary stent occlusion; and the recommended antiplatelet regimes that the patient with a coronary stent will be receiving. The role of preoperative platelet function testing is also discussed, and the various available tests are listed. Appropriate management by all the clinicians involved with patients with coronary stents undergoing a variety of non-cardiac surgical procedures is essential to avoid a high incidence of postoperative cardiac mortality and morbidity. The review examines the evidence available for the perioperative strategies aimed at reducing adverse outcomes in a number of different clinical scenarios.
引用
收藏
页码:560 / 574
页数:15
相关论文
共 135 条
[31]  
Eagle Kim A, 2004, Circulation, V110, pe340
[32]   Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events [J].
Eikelboom, JW ;
Hirsh, J ;
Weitz, JI ;
Johnston, M ;
Yi, Q ;
Yusuf, S .
CIRCULATION, 2002, 105 (14) :1650-1655
[33]   Recombinant activated factor VII for the treatment of life-threatening haemorrhage [J].
Eikelboom, JW ;
Bird, R ;
Blythe, D ;
Coyle, L ;
Gan, E ;
Harvey, M ;
Isbister, J ;
Leahy, M ;
McIlroy, D ;
Rahimpanah, F ;
Ramanthan, S ;
Strasser, S ;
Ward, C ;
Watts, A ;
Towler, S ;
Yi, QL .
BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (08) :713-717
[34]   Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction [J].
Eisenberg, MJ ;
Jamal, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) :1-6
[35]   Real-world bare metal stenting: Identification of patients at low or very low risk of 9-month coronary revascularization [J].
Ellis, SG ;
Bajzer, CT ;
Bhatt, DL ;
Brener, SJ ;
Whitlow, PL ;
Lincoff, AM ;
Moliterno, DJ ;
Raymond, RE ;
Tuzcu, EM ;
Franco, I ;
Dushman-Ellis, S ;
Lander, KJ ;
Schneider, JP ;
Topol, EJ .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 63 (02) :135-140
[36]   Coronary syndromes following aspirin withdrawal - A special risk for late stent thrombosis [J].
Ferrari, E ;
Benhamou, M ;
Cerboni, P ;
Marcel, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) :456-459
[37]   Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial [J].
Fitchett, DH ;
Langer, A ;
Armstrong, PW ;
Tan, M ;
Mendelsohn, A ;
Goodman, SG .
AMERICAN HEART JOURNAL, 2006, 151 (02) :373-379
[38]   Lowering cardiac risk in noncardiac surgery [J].
Fleisher, LA ;
Eagle, KA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1677-1682
[39]   Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical Revascularization for non-ST-elevation acute coronary syndrome - The Clopidogrel in Unstable Angina to prevent Recurrent Ischemic Events (CURE) trial [J].
Fox, KAA ;
Mehta, SR ;
Peters, R ;
Zhao, F ;
Lakkis, N ;
Gersh, BJ ;
Yusuf, S .
CIRCULATION, 2004, 110 (10) :1202-1208
[40]   Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy:: a double-blind placebo-controlled andomised trial [J].
Friederich, PW ;
Herny, CP ;
Messelink, EJ ;
Geerdink, MG ;
Keller, T ;
Kurth, KH ;
Büller, HR ;
Levi, M .
LANCET, 2003, 361 (9353) :201-205